Specifically, upregulation of CXCL10 has been linked to increased disease severity in both malaria (Wilson et al., 2011; Nie et al., 2009) and SCD (Driss et al., 2012; Harp et al., 2020). Here, CXCL10 is linked to Schnyder corneal dystrophy.